944 related articles for article (PubMed ID: 6411078)
1. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
2. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
3. [Effect of trapidil on prostacyclin formation by rabbit heart tissue].
Geling NG; Kudriashov SA
Biull Eksp Biol Med; 1982 Aug; 94(8):48-50. PubMed ID: 6751431
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
Mazurov AV; Leĭtin VL; Repin VS
Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
[TBL] [Abstract][Full Text] [Related]
5. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
6. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
7. Antianginal drug trapidil (Rocornal) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregates.
Mazurov AV; Leytin VL; Repin VS; Smirnov VN; Taube C; Förster V
Thromb Res; 1983 Nov; 32(3):255-66. PubMed ID: 6419377
[TBL] [Abstract][Full Text] [Related]
8. [Stimulation of prostacyclin biosynthesis as a possible mechanism of action of dipyridamole (author's transl)].
Mentz P; Pönicke K; Block HU; Giessler C; Blass KE; Bayer BL; Förster W
Arzneimittelforschung; 1981; 31(12):2075-82. PubMed ID: 7037009
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.
Salzman PM; Salmon JA; Moncada S
J Pharmacol Exp Ther; 1980 Oct; 215(1):240-7. PubMed ID: 7005425
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
11. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological properties of trapidil: comparison with other coronary vasodilators (author's transl)].
Ohnishi H; Kosuzume H; Yamaguchi K; Sato M; Umehara S; Funato H; Itoh C; Suzuki K; Kitamura Y; Suzuki Y; Itoh R
Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):495-503. PubMed ID: 7009345
[TBL] [Abstract][Full Text] [Related]
14. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
[TBL] [Abstract][Full Text] [Related]
15. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
Mehta J; Mehta P; Hay D
Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
[TBL] [Abstract][Full Text] [Related]
16. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
Schrör K; Moncada S; Ubatuba FB; Vane JR
Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313
[TBL] [Abstract][Full Text] [Related]
17. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
18. The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material".
Borda ES; Sterin-Borda L; Gimeno MF; Lazzari MA; Gimeno AL
Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):79-89. PubMed ID: 6342559
[TBL] [Abstract][Full Text] [Related]
19. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
20. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
Hwang DH
Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]